QIYU BIOTECH
Qi Xiangdong, founder of Qiyu Bio, said: “Innovation is the starting and future of Qiyu Bio, and it is the core driving force of enterprise development. Qiyu Bio will use the first-class antibody technology platform to build superior biopharmaceutical pipelines and explore the field of biotherapy. A big breakthrough. With the development and improvement of the company, Qiyu will have core competitiveness in more fields.
QIYU BIOTECH
Industry:
Biotechnology Health Care Medical
Founded:
2017-07-01
Address:
Shanghai, Shanghai, China
Country:
China
Total Employee:
11+
Status:
Active
Total Funding:
31.4 M USD
Similar Organizations
Cagen Bio
Cagen Bio is a vitro diagnostic reagents developer.
Dima Biotech
Dima Biotech is a cancer immunotherapy and monoclonal antibody developer.
Qihan Biotech
Qihan Biotech is a gene-editing organ transplantation technology developer.
Virogin Biotech
Virogin Biotech is an antineoplastic drug developer.
Yusu Biotech
Yusu Biotech is a hair care products developer.
Investors List
Tririver Capital
Tririver Capital investment in Series B - Qiyu Biotech
Oriza Prior
Oriza Prior investment in Series B - Qiyu Biotech
BOCOM International
BOCOM International investment in Series B - Qiyu Biotech
Shanghai Pudong Science and Technology Investment
Shanghai Pudong Science and Technology Investment investment in Series B - Qiyu Biotech
Longmen Capital
Longmen Capital investment in Series B - Qiyu Biotech
Watson Investment
Watson Investment investment in Series A - Qiyu Biotech
Jundu Investment
Jundu Investment investment in Series A - Qiyu Biotech